Paris Wallace is an enterprise expert who has founded two successful companies in the women+’s and reproductive health space. As co-founder of Ovia Health, the leading women+’s health and technology company focusing on fertility, pregnancy and parenting programs, Paris has helped empower women and families to take control of their healthcare. ​​As a recognized leader in the space, Ovia Health was acquired by Labcorp in 2021.

Prior to Ovia Health, Paris founded Good Start Genetics, a genomics technology company focused on fertility and reproductive health. His first effort in the health tech space made waves, resulting in Good Start Genetics’ acquisition by Invitae in 2017.

With a highly successful career thus far, Paris is not done yet. He is currently an entrepreneur in residence at Harvard Business School and is working on various diversity, equity and inclusion (DEI) and gender equality projects, providing a unique and impactful lens to entrepreneurship.

On July 20, Paris joined MATTER and Dr. Sheila Bhagavan from VillageMD to discuss his career, Ovia Health’s acquisition by Labcorp and what’s next in his journey.

This Tales from the Trenches™ is produced in partnership with VillageMD. 

For more information, visit matter.health and follow us on social:

LinkedIn @MATTER
Twitter @MATTERhealth
Instagram @matterhealth